# Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome

> **NCT02438982** · PHASE3 · COMPLETED · sponsor: **Nilratan Sircar Medical College** · enrollment: 120 (actual)

## Conditions studied

- Nephrotic Syndrome

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT02438982
- **Lead sponsor:** Nilratan Sircar Medical College
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-08
- **Primary completion:** 2016-08
- **Final completion:** 2016-09
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02438982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02438982, "Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02438982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*